Get started
Home/Hormone Optimization/CJC/Ipamorelin 1.2mg/2mg
Hormone Optimization CJC/Ipamorelin 1.2mg/2mg Injectable vial
Hormone Optimization

CJC/Ipamorelin 1.2mg/2mg

$430/month
Free shipping · Reviewed by a licensed clinician · Cancel anytime
FDA-registered pharmacy
Compounded in a licensed facility
Batch tested
Potency and sterility verified
Cold-chain shipping
Temperature controlled delivery
How it works
Three steps to your treatment
1
Complete your intake
Answer questions about your health history, lifestyle, and goals.
About 5 minutes
2
Clinician review
Our licensed clinicians evaluate your intake and prescribe your treatment.
Within 24 hours
3
Receive your treatment
Delivered to your door in 2 days, free shipping included.
2-day delivery
About this treatment
What is CJC/Ipamorelin Injectable?

CJC-1295 is a synthetic 30-amino-acid analogue of growth hormone-releasing hormone (GHRH) modified with a Drug Affinity Complex (DAC) — a chemical modification that allows the peptide to bind to serum albumin, extending its biological half-life from minutes to approximately 6-8 days. Ipamorelin is a pentapeptide growth hormone releasing peptide (GHRP) that activates the ghrelin receptor (GHS-R1a) to trigger GH secretion from the pituitary gland.

The two peptides work through complementary and distinct pathways: CJC-1295 binds to GHRH receptors on pituitary somatotroph cells, providing sustained baseline stimulation of GH production, while Ipamorelin acts through the ghrelin receptor to trigger acute, pulsatile GH release. This dual-pathway activation produces a synergistic amplification of growth hormone secretion — typically 2-3x greater than either peptide alone — while maintaining physiological release patterns.

What distinguishes this combination from other GH-stimulating protocols is Ipamorelin's remarkable selectivity. Unlike older GHRPs such as GHRP-6 or hexarelin, ipamorelin does not significantly increase cortisol, prolactin, or aldosterone levels, making it one of the cleanest growth hormone secretagogues available. This selectivity was established in the original 1998 characterization study and has been confirmed repeatedly in subsequent research.

The combined 1.2mg/2mg injectable formulation delivers both peptides subcutaneously for direct systemic absorption. The injectable route ensures maximum bioavailability of both peptides simultaneously, allowing the synergistic mechanism to function as designed for optimal growth hormone optimization under medical supervision.

Benefits
Key benefits
Synergistic GH Release
Dual-peptide mechanism amplifies growth hormone secretion 2-3x beyond single-peptide protocols by activating both GHRH and ghrelin receptor pathways simultaneously. This synergistic amplification is the primary advantage of the combined formulation.
Sleep Quality
Enhanced GH pulsatility during sleep supports deeper, more restorative rest cycles. Growth hormone's largest natural pulse occurs during slow-wave sleep, and optimizing this release may improve sleep architecture and morning recovery.
Body Composition
Supports lean muscle development and reduction of body fat through optimized GH and IGF-1 levels. Growth hormone promotes lipolysis (fat breakdown) while supporting protein synthesis, shifting body composition toward a leaner profile over time.
Recovery Support
Accelerated tissue repair and reduced recovery time between physical activities through enhanced collagen synthesis, protein turnover, and cellular regeneration. Athletes and active individuals often report faster return to training capacity.
Dosage
Treatment protocol
Dosing Your dosage is determined by your provider during your medical evaluation. Dosage may be adjusted over time based on your progress and response to treatment.
Frequency As prescribed based on your intake assessment
Administration Subcutaneous injection
Supplies Included with your prescription shipment
Included with your prescription
Eligibility
Is CJC/Ipamorelin Injectable Right for You?
May be appropriate for
  • Adults seeking growth hormone optimization and improved recovery
  • Individuals interested in evidence-based peptide therapy for body composition
  • Those experiencing age-related decline in GH levels under medical supervision
Not recommended for
  • Individuals with active malignancy or pituitary disorders
  • Pregnant or breastfeeding individuals
  • Those with uncontrolled diabetes or active retinopathy
Research
Clinical references
Teichman SL, et al. (2006) "Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295" Journal of Clinical Endocrinology & Metabolism. DOI: 10.1210/jc.2005-1528
Raun K, et al. (1998) "Ipamorelin, the first selective growth hormone secretagogue" European Journal of Endocrinology. DOI: 10.1530/eje.0.1390552
Johansen PB, et al. (1999) "Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats" Growth Hormone & IGF Research. DOI: 10.1054/ghir.1999.9998
Questions
Frequently asked questions
Why are CJC-1295 and Ipamorelin combined? +
The two peptides work through complementary mechanisms. CJC-1295 provides sustained GHRH stimulation with an extended half-life, while Ipamorelin delivers targeted GH pulses through the ghrelin receptor. Together they produce a more robust and physiologically natural GH response than either alone.
When is the best time to inject CJC/Ipamorelin? +
Your provider will determine the optimal timing for your protocol. Many patients administer injections in the evening, as this aligns with the body's natural nocturnal GH surge and may enhance sleep quality.
How long does a typical treatment cycle last? +
Most protocols run 3-6 months to achieve optimal results, followed by evaluation. Your provider may recommend cycling periods or continued maintenance depending on your response and health goals.
Will CJC/Ipamorelin affect my cortisol levels? +
Ipamorelin is notable for being a selective GH secretagogue that does not significantly affect cortisol, prolactin, or aldosterone levels, unlike some other GH-releasing peptides. This selectivity is one of the key advantages of this particular combination.

Ready to start?

Clinician-supervised, delivered to your door.